Our findings thus not only expand the understanding of GLP‐1 receptor agonists' cardiac benefits beyond metabolic regulation but also suggest the potential for more direct and possibly more effective cardioprotective strategies in the treatment of heart failure and related conditions. Here, GLP1R is linked to heart failure.